Navigation Links
3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010
Date:5/11/2010

SHENYANG, China, May 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the first quarter ended March 31, 2010 on May 16, 2010 at 8:00pm (Eastern).

Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on May 17, 2010 to discuss its 2010 first quarter financial results and recent business activity.

    The conference call may be accessed using the dial-in numbers below:

    Conference ID: 74760426

    Local dial-in:
    China - landline 800 819 0121
    China - mobile 400 620 8038
    Hong Kong - 852 2475 0994

    International toll-free dial-in:
    Hong Kong 800 930 346
    United Kingdom 080 8234 6646
    United States 1 866 519 4004
    International toll dial-in: 65 6723 9381

A telephone replay will be available two hours after the call until May 24, 2010 at:

    International dial-in: +61-2-8235-5000
    United States dial-in: 1-866-214-5335
    Replay- Conference ID: 74760426

Webcast

A live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/3sbio2010Q1 . A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3SBio.com

    Investor Contacts

     Bo Tan
     Chief Financial Officer
     3SBio Inc.
     Tel:   +86-24-2581-1820
     Email: ir@3SBio.com

     Tom Folinsbee
     Director of Investor Relations
     3SBio Inc.
     Tel:   +852-8191-6991
     Email: ir@3SBio.com


'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 3SBio Announces Changes to its Board of Directors
2. 3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial
3. 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
4. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
5. 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
6. 3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010
7. 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
8. 3SBio Inc. Announces Unaudited Third Quarter 2009 Results
9. 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
10. 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
11. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the business of innovation is taking over sports. On Thursday, December 15th a ... how technology is disrupting the playing field at a Smart Talk session. Smart ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and type 2 ... license for a novel adeno-associated virus (AAV) vector ... Kay , M.D., Ph.D., at Stanford University. The ... of its paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that provide essential device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, ... The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard 204-pin ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
Breaking Biology Technology:
(Date:11/28/2016)... LONDON , Nov. 28, 2016 ... at a rate of 16.79%" The biometric system ... to grow further in the near future. The biometric ... 32.73 billion in 2022, at a CAGR of 16.79% ... biometrics system, integration of biometric technology in smartphones, rising ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
Breaking Biology News(10 mins):